Log in to save to my catalogue

Fosfomycin in continuous or prolonged infusion for systemic bacterial infections: a systematic revie...

Fosfomycin in continuous or prolonged infusion for systemic bacterial infections: a systematic revie...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8139892

Fosfomycin in continuous or prolonged infusion for systemic bacterial infections: a systematic review of its dosing regimen proposal from in vitro, in vivo and clinical studies

About this item

Full title

Fosfomycin in continuous or prolonged infusion for systemic bacterial infections: a systematic review of its dosing regimen proposal from in vitro, in vivo and clinical studies

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

European journal of clinical microbiology & infectious diseases, 2021-06, Vol.40 (6), p.1117-1126

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Fosfomycin (FOS) administered intravenously has been recently rediscovered for the treatment of systemic infections due to multidrug-resistant bacteria. Its pharmacokinetic properties suggest a time-dependent dosing schedule with more clinical benefits from prolonged (PI) or continuous infusion (CI) than from intermittent infusion. We revised liter...

Alternative Titles

Full title

Fosfomycin in continuous or prolonged infusion for systemic bacterial infections: a systematic review of its dosing regimen proposal from in vitro, in vivo and clinical studies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8139892

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8139892

Other Identifiers

ISSN

0934-9723,1435-4373

E-ISSN

1435-4373

DOI

10.1007/s10096-021-04181-x

How to access this item